U.S. Vascular Access Devices Market: $2.78B by 2035

Market Outlook

By 2035, the U.S. Vascular Access Devices Market is expected to reach approximately USD 2.78 billion, growing at a CAGR of 6.58% during the forecast period 2026-2035. The core device market was valued at USD 1.47 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions. The sizing scope includes peripheral intravenous catheters, central venous catheters, peripherally inserted central catheters, midline catheters, implantable ports, port-access needles, intraosseous access systems, introducer and guidewire kits, needleless connectors, stabilization products, catheter guidance technologies, tip-positioning systems, and selected infection-prevention accessories. Infusion pumps, IV fluids, general-purpose syringes, dialysis machines, and therapeutic vascular intervention devices are excluded to maintain a clinically coherent vascular access definition.

The U.S. vascular access devices industry is a high-frequency, workflow-critical segment of medical care because reliable venous or intraosseous access is required before many medications, fluids, blood products, contrast agents, parenteral nutrition regimens, chemotherapy protocols, emergency resuscitation pathways, and hemodialysis treatments can be delivered. The installed clinical base is exceptionally large. U.S. hospitals reported more than 34.4 million admissions and over 913,000 staffed beds in the latest 2025 hospital statistics release, while peripheral IV catheters remain among the most frequently used invasive devices in acute care. This procedure density creates a durable recurring-consumables market rather than a market dependent on isolated capital-equipment replacement cycles.

Demand is shifting from low-cost catheter procurement toward a broader value proposition built around first-attempt success, longer dwell, fewer restarts, reduced blood exposure, lower catheter-related infection risk, prevention of accidental dislodgement, drug-compatible materials, reliable power injection, standardized placement protocols, and faster confirmation of catheter-tip position. Large U.S. health systems increasingly evaluate vascular access products through total episode economics. A device with a higher acquisition price can be favored when it reduces nursing time, avoids repeat insertion, decreases radiography, limits central-line escalation, supports earlier discharge, or lowers the risk of central line-associated bloodstream infection and thrombosis.

The historical market expanded from an estimated USD 1.17 billion in 2021 to USD 1.40 billion in 2024. Growth during this period was supported by the normalization of elective oncology care, higher inpatient acuity, expanded infusion-center capacity, increased use of midlines and ultrasound-guided access, and renewed hospital spending on infection-control technologies. The market reached USD 1.47 billion in 2025. Under the report model, it is projected to cross USD 2.02 billion by 2030 and reach USD 2.78 billion by 2035 as premium safety-engineered, anti-thrombogenic, closed-system, ultrasound-guided, and digitally documented access solutions gain a larger share of procedure value.

Introduction

According to the U.S. Vascular Access Devices Market Report, vascular access is best understood as a clinical pathway rather than a single catheter category. The pathway begins with vessel assessment and device selection, continues through insertion, stabilization, tip confirmation, access and maintenance, and ends with removal and complication surveillance. Procurement decisions therefore involve nursing leadership, vascular access teams, infection prevention, pharmacy, emergency medicine, oncology, nephrology, radiology, critical care, supply chain, value analysis committees, and finance. Manufacturers that solve only the insertion step face increasing competition from companies that provide connected product portfolios covering assessment, placement, securement, access, maintenance, and data-supported quality improvement.

The U.S. market includes several distinct demand pools. Short peripheral IV catheters generate very high unit volume and are used across emergency departments, inpatient units, outpatient surgery, imaging, and ambulatory infusion. PICCs and midlines serve patients requiring intermediate or extended intravenous therapy. Central venous catheters remain essential in intensive care, perioperative medicine, hemodynamic monitoring, complex infusion, and rapid administration. Implantable ports are closely tied to oncology and other long-duration treatment regimens. Dialysis catheters serve acute and chronic renal care, while intraosseous systems provide time-sensitive access when conventional IV placement is delayed or impractical.

Clinical demand is reinforced by the scale of U.S. chronic disease. The National Cancer Institute estimated more than 2.04 million new cancer diagnoses in 2025, and a substantial portion of systemic cancer therapy depends on repeated vascular access. The U.S. Renal Data System reported 131,564 people starting treatment for end-stage kidney disease in 2023, creating continued demand for dialysis access and for bridging catheters when permanent access is unavailable or not yet mature. In parallel, sepsis, dehydration, trauma, surgery, infection treatment, biologic drug administration, and diagnostic imaging generate recurring demand across virtually every hospital service line.

From 2026 to 2035, the defining market theme will be appropriateness of device selection. Hospitals are trying to reduce the common pattern in which a low-acuity peripheral catheter repeatedly fails and is replaced, or a central device is placed earlier than clinically necessary. Vascular access algorithms increasingly match device length, lumen count, material, tip location, anticipated dwell, infusate characteristics, vein diameter, patient anatomy, and care setting. This favors companies able to support evidence-based device selection, ultrasound competency, catheter-to-vein ratio assessment, standardized kits, and longitudinal quality reporting.

Key Market Drivers: What’s Fueling the U.S. Vascular Access Devices Market Boom?

The first major driver is the extraordinary procedure frequency of intravenous therapy in the United States. Most hospitalized patients require some form of vascular access, and the national volume of peripheral catheter placement is measured in the hundreds of millions of procedures. Even modest improvements in first-stick success, dwell time, blood-containment, and avoidance of replacement can therefore produce meaningful labor and supply savings at system scale. This volume also makes vascular access a strategically important standardization category for integrated delivery networks that seek fewer stock-keeping units, consistent clinical practice, and enterprise-level contracting.

A second driver is the expanding burden of oncology and infusion-intensive chronic disease. More than 2.04 million new U.S. cancer cases were estimated for 2025, while the survivor population is projected to continue rising. Cancer treatment increasingly combines intravenous chemotherapy, immunotherapy, targeted biologics, supportive hydration, blood sampling, transfusion, and contrast-enhanced imaging. This supports demand for implantable ports, power-injectable PICCs, midlines, non-coring safety needles, needleless connectors, stabilization devices, and access-maintenance products. Oncology buyers place particular emphasis on patient comfort, reliable long-term access, compatibility with high-pressure injection, and reduction of occlusion or infection-related treatment interruption.

A third driver is end-stage kidney disease and dialysis access. The U.S. Renal Data System recorded 131,564 new treatment starts for end-stage kidney disease in 2023, and the proportion of incident patients using home dialysis increased materially over the previous decade. Although arteriovenous fistulas and grafts remain preferred for durable hemodialysis access, tunneled and non-tunneled dialysis catheters remain necessary for urgent starts, temporary access, access failure, and selected patients with limited options. This sustains demand for high-flow catheters, antimicrobial barrier products, catheter-lock compatible components, dressing and securement products, and infection surveillance solutions.

A fourth driver is the persistent clinical and economic burden of catheter-associated complications. The Centers for Disease Control and Prevention estimated that approximately 18,100 central line-associated bloodstream infections still occur annually in U.S. acute-care intensive care units and wards, despite a 10% national decrease from 2023 to 2024. CLABSI events extend length of stay, increase treatment cost, consume infection-prevention resources, and expose hospitals to quality penalties and reputational risk. This supports procurement of maximal barrier kits, antimicrobial dressings and caps, disinfecting connectors, closed IV systems, blood-control catheters, anti-thrombogenic materials, securement devices, and standardized maintenance bundles.

A fifth driver is difficult intravenous access. Older age, obesity, dehydration, edema, diabetes, end-stage kidney disease, prior chemotherapy, repeated hospitalization, and a history of injection drug use can make conventional landmark-guided insertion unreliable. Failed attempts consume nursing time, delay medication, increase patient dissatisfaction, and can cause escalation to more invasive devices. Hospitals are therefore investing in portable ultrasound, needle-tracking software, longer peripheral catheters, rapid-access midlines, specialized vascular access teams, and competency programs. The market opportunity is not limited to the catheter; it includes the technology, training, documentation, and procedural kit required to improve first-attempt success.

A sixth driver is the shift of infusion therapy beyond the traditional inpatient setting. Hospital outpatient departments, cancer centers, physician-owned infusion clinics, ambulatory surgery centers, dialysis facilities, skilled nursing facilities, and home infusion providers are managing a larger share of therapy. Medicare has maintained a defined home infusion therapy benefit for eligible services since 2021, including professional support, education, and monitoring associated with certain pump-administered drugs. Outpatient and home settings favor devices that are easy to maintain, resistant to accidental dislodgement, compatible with remote clinical oversight, and designed for lower-complexity staffing models.

A seventh driver is hospital capital and supply procurement behavior. Vascular access products historically competed heavily on unit price, but U.S. hospital buyers are increasingly linking procurement to nursing productivity and quality metrics. A single failed peripheral IV may trigger additional catheters, start kits, ultrasound use, specialist consultation, treatment delay, and staff time. Conversely, a more expensive device may prevent escalation to a PICC or central venous catheter. The procurement conversation is consequently moving toward cost per successful therapy day, cost per completed treatment course, complication-adjusted cost, and total number of insertion attempts rather than simple purchase price.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. vascular access devices market is being directed toward biological compatibility, procedural precision, infection prevention, and workflow simplification. The next generation of products is designed not only to enter a vessel but also to remain functional for the intended therapy duration with fewer complications and less maintenance. This is changing the competitive basis of the market from catheter geometry alone to a combined platform of materials science, placement technology, securement, connector design, clinical education, and outcomes evidence.

Advanced catheter materials are a major innovation area. Manufacturers are developing hydrophilic, anti-thrombogenic, antimicrobial, and low-friction surfaces intended to reduce protein adhesion, thrombus accumulation, occlusion, and tissue irritation. In 2025, the FDA cleared expanded labeling for Access Vascular HydroPICC and HydroMID catheter lines recognizing anti-thrombogenic properties associated with their drug-free hydrogel material. The commercial significance is broader than one product family: it demonstrates that material-level differentiation can become a clinically and economically meaningful purchasing criterion in a category long treated as a commodity.

Placement guidance is also advancing. Portable ultrasound has become central to difficult-access programs, and newer systems combine optimized probes, needle visualization, vessel measurement, and software-assisted tracking. ECG-based tip confirmation and magnetic navigation can reduce dependence on post-placement chest radiography for eligible PICC procedures, accelerating therapy initiation and freeing radiology capacity. The highest-value platforms are those that integrate imaging, navigation, documentation, and consumables while fitting the workflow of nurse-led vascular access teams.

Closed and blood-control peripheral IV systems are gaining importance because they reduce the number of open connections and may limit blood exposure during insertion and connection. Integrated extension sets, stabilization platforms, passive safety mechanisms, and needle encapsulation can simplify workflow and support occupational safety. These features are particularly relevant in high-turnover emergency departments, perioperative units, and outpatient centers where multiple staff members may access the line and where standardization is essential for reliable compliance.

Needleless connector innovation is moving beyond mechanical convenience toward infection-control evidence. In 2025, ICU Medical announced FDA-cleared labeling for its Clave connector portfolio that incorporated study findings from approximately 3,000 hospitals and 17.5 million catheter-days, indicating a 19% lower relative risk of CLABSI in hospitals with high use of the technology. This development illustrates how real-world evidence can change the value proposition of a small disposable component when its impact is measured across large device-day volumes.

Emergency vascular access is another active area. In October 2024, BD launched an enhanced intraosseous vascular access system for adult and pediatric use in U.S. emergency settings. Published evidence cited with the launch indicated trained-inserter success rates of 93% to 97%, highlighting why intraosseous access is increasingly viewed as a standardized rescue pathway rather than a last-resort technique. Innovation is focused on powered drivers, passive needle safety, multiple needle lengths, stabilization, and rapid readiness across emergency departments, trauma services, ambulances, and military or disaster-response environments.

Manufacturers are also raising the bar through evidence and implementation services. U.S. buyers increasingly expect comparative dwell data, complication rates, device-day utilization, time-to-therapy analysis, staff training metrics, and budget-impact models. Companies able to support product trials, baseline measurement, protocol redesign, and post-conversion surveillance are better positioned than suppliers offering price concessions without clinical integration. Over the forecast period, commercial success will depend on demonstrating that a product improves the reliability of therapy delivery rather than simply meeting technical specifications.

Segmentation Insights

The U.S. Vascular Access Devices Market is segmented on the basis of product type, application, end user, technology type, and region. The following segmentation reflects clinical use patterns, purchasing channels, device duration, procedure complexity, and revenue contribution in the United States.

By Product Type

Peripheral intravenous catheters. Peripheral IV catheters represent the largest product category by unit volume and an estimated 35% of 2025 market revenue. The segment includes conventional short PIVCs, safety catheters, blood-control catheters, closed IV catheter systems, long peripheral catheters, and integrated catheter-extension configurations. Demand is broadly distributed across emergency care, inpatient medicine, surgery, imaging, outpatient infusion, pediatrics, and skilled nursing. Growth is value-led rather than volume-led, with premium expansion coming from passive safety, blood containment, integrated securement, longer dwell, and ultrasound-compatible designs.
Central venous catheters. Central venous catheters account for an estimated 24% of market value and include non-tunneled CVCs, tunneled catheters, hemodialysis catheters, antimicrobial catheters, introducer sheaths, and multi-lumen critical-care configurations. Hospitals remain the principal buyers because these devices are used in intensive care, surgery, trauma, complex infusion, hemodynamic monitoring, and renal replacement therapy. The category has mature baseline demand, but premium growth is supported by infection-prevention features, pressure-injection capability, optimized flow, antimicrobial or anti-thrombogenic technologies, and complete maximal-barrier kits.
Peripherally inserted central catheters and midlines. PICCs and midlines together represent approximately 19% of 2025 revenue and are among the most strategically dynamic categories. PICCs are used for longer-duration central access, while midlines are increasingly selected for intermediate-duration therapy that does not require a central tip. The shift toward midlines is driven by efforts to avoid unnecessary central-line placement, reduce radiography, and improve outpatient continuity. Growth is strongest in power-injectable devices, dual-lumen designs, accelerated Seldinger placement, anti-thrombogenic materials, and integrated tip-navigation systems.
Implantable ports and port-access needles. Implantable venous ports and associated non-coring safety needles account for an estimated 13% of market value. The segment is closely linked to oncology, hematology, long-term antibiotic therapy, and selected chronic conditions requiring recurrent access. Ports offer long-duration access with a lower external-device burden when not accessed, supporting patient mobility and quality of life. U.S. buyers prioritize low-profile designs, power injection, MRI compatibility, reliable septum performance, patient comfort, and safety needles that reduce accidental needlestick risk during repeated access.
Intraosseous systems, introducers, connectors, securement, and accessories. The remaining market includes intraosseous access systems, guidewires, introducer needles, peel-away sheaths, needleless connectors, disinfection caps, stabilization devices, dressings, extension sets, and tip-positioning accessories. Although individually smaller, these categories generate attractive recurring revenue and influence the performance of the full access pathway. The fastest growth is expected in products with measurable infection-control, dislodgement-reduction, or workflow benefits and in accessories that can be standardized across multiple catheter types.

By Application

Medication, fluid, blood product, and nutritional therapy. General therapeutic infusion is the largest application, representing an estimated 34% of 2025 market value. It includes hydration, antibiotics, analgesics, vasoactive medications, blood products, total parenteral nutrition, and routine inpatient IV therapy. Product selection depends on infusate properties, expected duration, patient vein condition, and care setting. Health systems are increasingly formalizing device-selection pathways to prevent both under-treatment with repeatedly failing short PIVCs and overuse of central access for therapies that can be delivered through an appropriate peripheral or midline device.
Oncology and hematology. Oncology and hematology account for approximately 24% of market value because repeated treatment cycles, vesicant administration, blood sampling, transfusion, and diagnostic imaging create substantial demand for durable access. Implantable ports, PICCs, power-injectable devices, port needles, and needleless connectors are core products. The U.S. oncology market is supported by more than 2.04 million estimated new cancer cases in 2025 and a growing survivor population. Device value is determined by reliability across repeated cycles, compatibility with therapy protocols, low maintenance burden, and reduction of treatment disruption.
Critical care, surgery, trauma, and emergency medicine. This application represents an estimated 19% of the market and includes multi-lumen CVCs, rapid-infusion access, arterial access kits, intraosseous devices, introducers, and short peripheral catheters. Demand is linked to the scale of U.S. hospital admissions, emergency visits, major surgery, sepsis, and trauma. In critical settings, product attributes such as rapid setup, clear packaging, multiple size options, passive needlestick protection, high flow, secure fixation, and compatibility with pressure monitoring can influence adoption more than modest unit-price differences.
Renal care and dialysis. Renal care represents approximately 13% of market value. The segment includes acute dialysis catheters, tunneled chronic hemodialysis catheters, antimicrobial barrier caps, securement products, guidewires, and maintenance accessories. The U.S. Renal Data System reported 131,564 new end-stage kidney disease treatment starts in 2023. While national policy encourages permanent access and home modalities, catheter demand remains significant because of urgent dialysis starts, temporary access needs, access failure, hospitalization, and patients who are not candidates for fistula or graft placement.
Diagnostic imaging, blood sampling, and specialty therapy. The remaining application share includes power injection for CT and MRI, contrast administration, repeated blood collection, biologic therapy, apheresis, and specialty infusions. Growth is supported by power-injectable catheters and ports, integrated blood-draw devices, and systems that reduce repeated needle sticks. Diagnostic workflows value clear pressure ratings, reliable flow, standardized labeling, and compatibility with contrast protocols, while blood-sampling applications increasingly favor needle-free solutions that preserve existing peripheral access.

By End User

Hospitals and integrated health systems. Hospitals are the dominant end users, accounting for an estimated 61% of 2025 revenue. The United States reported 6,093 hospitals, more than 913,000 staffed beds, and approximately 34.4 million annual admissions in the 2025 AHA statistics release. Hospitals purchase the broadest product range and are the primary users of CVCs, PICCs, midlines, intraosseous systems, advanced ultrasound, and infection-prevention accessories. Large systems increasingly negotiate enterprise contracts, standardize product families, and require vendor support for training, conversion, utilization analytics, and complication reduction.
Cancer centers, infusion clinics, and physician practices. These settings represent approximately 15% of market value and are important users of ports, PICCs, midlines, safety needles, connectors, extension sets, and securement products. Their purchasing priorities differ from inpatient hospitals. They place greater emphasis on repeated-access comfort, predictable scheduling, low maintenance burden, patient education, and continuity between clinic and home. Independent and hospital-owned infusion networks also favor simplified formularies that support multiple therapy protocols without excessive inventory complexity.
Ambulatory surgery centers and hospital outpatient departments. These users account for approximately 10% of revenue and are growing as procedures migrate outside the inpatient setting. Short PIVCs, safety catheters, blood-control systems, ultrasound-guided access products, and rapid-start kits are the most relevant categories. Outpatient economics favor products that minimize preparation time, reduce failed starts, and allow fast patient turnover. Vendors must demonstrate value within shorter episodes of care, where the economic cost of a delayed procedure or repeated insertion can be more visible than the long-term complication profile.
Dialysis facilities and renal-care providers. Dialysis providers represent approximately 9% of market value, concentrated in tunneled and acute dialysis catheters, high-flow designs, access-maintenance products, antimicrobial caps, securement, and dressing systems. This channel is highly protocol driven and influenced by infection metrics, chain-level contracting, and compatibility with established dialysis equipment and workflows. Manufacturers with strong clinical evidence and supply reliability can obtain broad network adoption, but pricing pressure is significant because large providers manage substantial recurring device volumes.
Home infusion, skilled nursing, emergency medical services, and other care settings. These settings account for the remaining 5% of market revenue but are expected to grow faster than the average. Home infusion requires durable access, patient and caregiver education, easy-to-use connectors, and securement that supports mobility. Skilled nursing facilities need standardized products that reduce complexity across variable staffing levels. Emergency medical services value compact kits, rapid intraosseous access, and rugged device readiness. The commercial opportunity is strongest for products designed around safe use outside a highly specialized hospital environment.

By Technology Type

Conventional catheter and port technologies. Conventional devices remain the largest technology class, accounting for approximately 44% of 2025 revenue. The segment includes standard peripheral catheters, polyurethane and silicone central catheters, conventional PICCs and midlines, and established implantable ports. These products provide the market baseline and remain important in price-sensitive facilities. Growth will be slower than the overall market as hospitals selectively upgrade high-risk or high-volume pathways to safety-engineered and complication-reducing technologies.
Safety-engineered and blood-control systems. Safety-engineered products account for approximately 30% of market value and include passive needle shielding, needle encapsulation, blood-control valves, closed IV catheter systems, safety port needles, and integrated extension configurations. Occupational safety regulations and hospital efforts to reduce blood exposure support adoption. The strongest products combine safety with workflow efficiency; devices that add steps or require substantial retraining may face resistance even when they provide technical protection.
Antimicrobial, anti-thrombogenic, and complication-reducing materials. This technology class represents approximately 10% of 2025 revenue but is projected to grow at an above-market rate. It includes antimicrobial catheters, chlorhexidine-based barrier products, anti-thrombogenic hydrogel materials, disinfecting caps, and specialized surface treatments. Adoption depends on credible evidence, regulatory labeling, compatibility with existing protocols, and a clear budget-impact case. Hospitals with elevated infection rates, complex oncology populations, or high central-line utilization are likely to be the earliest premium adopters.
Ultrasound guidance, navigation, and tip confirmation. Guidance technologies represent approximately 9% of market value when associated disposables and placement systems are included. Portable ultrasound, needle tracking, vessel measurement, magnetic navigation, and ECG-based tip confirmation can improve placement confidence and reduce delays. Their economic value is greatest in hospitals with dedicated vascular access teams and large difficult-access populations. Vendors are increasingly bundling capital systems with compatible catheters, service, and training to create recurring platform revenue.
Needleless, closed-system, and digitally supported access. Needleless connectors, closed fluid pathways, blood-draw devices, and digital documentation tools account for approximately 7% of the market. Their strategic influence is larger than their current revenue share because they affect infection prevention, line access frequency, nursing workflow, and data capture. Over the forecast period, hospitals are expected to connect device selection with electronic documentation, competency tracking, and quality dashboards, creating opportunities for software-supported vascular access programs.

Regional Insights: Where the Market is Growing Fastest

The U.S. Vascular Access Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, cancer incidence, kidney disease burden, hospital density, academic medical-center concentration, rural access gaps, outpatient infusion capacity, and adoption of specialized vascular access teams. The South is the largest region by revenue, the West is expected to record the fastest growth through 2035, the Northeast has the highest concentration of premium academic and oncology demand, and the Midwest provides a stable base of hospital, dialysis, and manufacturing-linked procurement.

South

The South is the largest regional market, accounting for an estimated USD 0.56 billion in 2025, or approximately 38% of U.S. revenue. It includes Texas, Florida, Georgia, North Carolina, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia, Delaware, and the District of Columbia under the report’s commercial mapping. The region combines a large and growing population, substantial chronic disease burden, major hospital systems, high oncology and dialysis demand, and broad rural-to-urban variation in care delivery.

Texas is the largest state opportunity in the South. Houston, Dallas-Fort Worth, San Antonio, and Austin support high-volume academic centers, trauma programs, oncology networks, transplant programs, and integrated delivery systems. The state is attractive for peripheral IV standardization, advanced PICC and midline programs, intraosseous emergency access, and dialysis catheter demand. Large geographic distances also support outpatient and home infusion models, making securement, patient education, and low-maintenance access important commercial differentiators.

Florida is another major state market because of its older population, dense hospital and ambulatory-care infrastructure, high cancer treatment volume, and large Medicare population. Demand is particularly strong for implantable ports, port-access needles, PICCs, midlines, and renal-access products. Population migration into Central and Southwest Florida is encouraging health-system expansion and new outpatient infusion capacity. Procurement is increasingly centralized across large regional systems, favoring suppliers that can cover both inpatient and ambulatory channels with a consistent product architecture.

North Carolina, Georgia, Tennessee, Virginia, and Maryland are high-value growth states. North Carolina and Tennessee combine academic medical centers with large community networks and life-sciences activity. Georgia has a rapidly expanding metropolitan population and substantial rural-access needs. Virginia and Maryland benefit from dense hospital systems, federal and military medical activity, and sophisticated oncology and critical-care programs. These states are favorable for ultrasound-guided access, vascular access team expansion, and enterprise infection-prevention initiatives.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, West Virginia, and South Carolina have smaller revenue bases but meaningful demand linked to diabetes, kidney disease, rural hospital reliance, and limited specialist availability in some areas. Technologies that reduce transfer, avoid unnecessary central access, or enable reliable therapy in community settings can generate disproportionate value. The South is projected to reach approximately USD 1.05 billion by 2035, expanding at an estimated 6.49% CAGR, supported by population growth, oncology capacity, dialysis utilization, and hospital network consolidation.

West

The West represented an estimated USD 0.31 billion in 2025 and is expected to be the fastest-growing region, reaching approximately USD 0.68 billion by 2035 at an estimated 8.17% CAGR. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Growth is supported by population expansion in the Mountain West, a strong innovation ecosystem, high adoption of ultrasound and digital workflow tools, and significant outpatient and home-based care development.

California is the largest state market in the West and one of the most influential vascular access markets nationally. It combines large academic health systems, major cancer centers, high procedure volume, advanced nursing practice, and a dense medtech and digital-health ecosystem. California providers are important early adopters of closed IV systems, ultrasound-guided access, evidence-based midline use, blood-draw devices, anti-thrombogenic materials, and data-driven quality programs. The state also has substantial diversity in payer mix and facility economics, requiring both premium and value-oriented commercial strategies.

Arizona, Nevada, Colorado, and Utah are expected to generate above-average growth. Arizona and Nevada benefit from rapid population growth and increasing older-adult demand, supporting oncology, renal, hospital, and ambulatory infusion services. Colorado and Utah have strong integrated delivery networks and a high level of clinical standardization, making them attractive for platform conversions that bundle ultrasound, catheters, and implementation support. These states also have expanding outpatient footprints, which favors simple, durable, and lower-maintenance access systems.

Washington and Oregon are important for evidence-driven procurement, infection prevention, and connected care. Health systems in these states often evaluate new devices through centralized clinical committees and are receptive to products with real-world evidence, environmental advantages, and measurable workflow outcomes. Idaho, Montana, Wyoming, Alaska, New Mexico, and Hawaii are smaller markets but have strategic need for reliable access across rural and geographically dispersed care settings. Portable ultrasound, long peripheral catheters, emergency intraosseous systems, and home infusion support have particular relevance in these states.

The West is also the region most likely to link vascular access with digital documentation and clinical analytics. Academic centers and technology-oriented health systems are increasingly interested in tracking device selection, insertion attempts, dwell, complications, and line necessity through electronic workflows. This creates an opportunity for suppliers to differentiate through data integration and quality-improvement services rather than only product attributes.

Northeast

The Northeast accounted for an estimated USD 0.33 billion in 2025 and is projected to reach approximately USD 0.59 billion by 2035, reflecting an estimated 5.98% CAGR. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, Vermont, and Delaware in standard Census-style mapping. Its market strength comes from academic medical centers, high specialist density, major cancer institutions, complex inpatient care, and rigorous value-analysis processes.

New York is the largest state market in the Northeast. New York City and the surrounding metropolitan area have extensive academic, oncology, transplant, trauma, and specialty-care infrastructure, while upstate health systems serve broad regional populations. Demand spans premium ports, PICCs, midlines, CVCs, safety catheters, dialysis access, and ultrasound-guided placement. Large systems increasingly seek product standardization across flagship academic hospitals, community facilities, ambulatory centers, and home-care networks.

Pennsylvania and New Jersey provide substantial procedure volume and a balanced mix of academic and community care. Pennsylvania has major health systems in Philadelphia, Pittsburgh, and central regions, supporting high-acuity central access and broad peripheral catheter demand. New Jersey has dense hospital and oncology networks and significant pharmaceutical and life-sciences activity, contributing to infusion demand. Both states are attractive for clinical conversion programs that require strong education and supply reliability across multiple facilities.

Massachusetts is strategically important despite its smaller population because of its concentration of academic medicine, clinical research, medtech innovation, and specialized vascular access expertise. Connecticut, Rhode Island, New Hampshire, Vermont, and Maine are smaller but mature markets with high expectations for evidence, infection prevention, and standardized care. Rural northern New England also creates a need for durable outpatient and home infusion access. The Northeast will grow more slowly than the West because of demographic maturity, but it is expected to maintain premium pricing and early adoption of high-evidence technologies.

Midwest

The Midwest represented an estimated USD 0.27 billion in 2025 and is forecast to reach approximately USD 0.46 billion by 2035, expanding at an estimated 5.47% CAGR. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. Demand is supported by large community-hospital networks, established academic centers, significant dialysis utilization, and mature procurement relationships with major medtech manufacturers and distributors.

Illinois, Ohio, Michigan, and Minnesota are the largest state opportunities. Chicago supports a dense academic and community hospital ecosystem, oncology capacity, and major outpatient networks. Ohio has high-volume hospital systems and a strong mix of urban and regional care. Michigan has substantial demand for inpatient, oncology, and renal access. Minnesota is strategically important because of its medtech heritage, clinical expertise, and large integrated delivery networks that can influence product evaluation and contracting beyond the state.

Indiana, Wisconsin, Missouri, Iowa, and Kansas provide stable demand for safety PIVCs, PICCs, midlines, dialysis catheters, and hospital-based CVCs. These states often emphasize total cost, supply continuity, and ease of implementation. Conversion decisions may move more slowly than in innovation-intensive coastal markets, but adoption can be durable once a product is standardized. Vendors that maintain strong field education and distributor relationships can achieve broad penetration across community facilities.

Nebraska, North Dakota, and South Dakota are smaller markets with dispersed populations and important rural referral networks. Access to specialized vascular teams can be uneven, increasing the value of portable ultrasound, simplified midline systems, emergency intraosseous devices, and tele-education. The Midwest is not expected to lead national growth, but it remains a reliable market for high-volume consumables and system-wide standardization initiatives.

Key Market Players

The U.S. Vascular Access Devices Competitive Landscape is moderately consolidated in high-volume peripheral IV, central catheter, PICC, midline, port, and connector categories, with several large medtech companies controlling broad portfolios and national distribution. At the same time, specialized innovators are creating competition in anti-thrombogenic materials, dislodgement prevention, blood-draw access, ultrasound guidance, and infection-control accessories. The market supports both platform companies and focused innovators because a single clinically differentiated component can influence outcomes across millions of catheter-days.

Competition is increasingly platform based. Leading suppliers seek to cover vessel assessment, insertion, catheter selection, tip confirmation, securement, needleless access, disinfection, and maintenance. Broad portfolios enable bundling and enterprise contracts, but they also create vulnerability when hospitals demand product-neutral evidence or want to avoid single-vendor dependency. Smaller companies can gain share by solving a specific workflow problem, generating credible real-world evidence, and partnering with distributors or larger manufacturers for national reach.

Some of the key players in the U.S. Vascular Access Devices industry are

Becton, Dickinson and Company (BD)
Teleflex Incorporated
ICU Medical, Inc.
B. Braun Medical Inc.
Cardinal Health, Inc.
Medline Industries, LP
AngioDynamics, Inc.
Cook Medical
Merit Medical Systems, Inc.
Argon Medical Devices, Inc.
Vygon USA
Terumo Medical Corporation
Nipro Medical Corporation
Fresenius Medical Care
Baxter International Inc.
Solventum Corporation
Access Vascular, Inc.
Linear Health Sciences, LLC
Adhezion Biomedical, LLC
Nexus Medical, LLC
Eloquest Healthcare, Inc.
Dale Medical Products, Inc.
pfm medical, inc.
Utah Medical Products, Inc.
Numantec / Health Line International

BD, Teleflex, ICU Medical, and B. Braun have the broadest strategic positions because they combine peripheral access, central access, guidance, connectors, safety, and infusion-related products. Cardinal Health and Medline are influential through distribution, private-label capabilities, and enterprise supply relationships. AngioDynamics, Cook Medical, Merit Medical, Argon, Vygon, Terumo, and Nipro compete across specialty catheters, ports, introducers, and procedural kits. Fresenius Medical Care has particular relevance in renal access, while Solventum, Adhezion, Eloquest, and Dale Medical participate in securement, skin preparation, and line-maintenance workflows.

Access Vascular and Linear Health Sciences represent the innovation-driven segment of the market. Access Vascular is differentiating through anti-thrombogenic hydrogel catheter materials, while Linear Health Sciences focuses on a safety release valve intended to reduce accidental line dislodgement. Competitive position through 2035 will be influenced by FDA clearances, real-world evidence, contract access, supply reliability, clinical education capacity, and the ability to prove lower complication-adjusted cost. Companies that can demonstrate reductions in restarts, delays, infections, thrombosis, dislodgement, radiography, and nursing time will be best positioned to defend premium pricing.

Recent Developments

Recent developments in the U.S. Vascular Access Devices Market show a clear shift toward evidence-backed complication prevention and more reliable emergency access. In October 2024, BD launched an enhanced intraosseous vascular access system for adult and pediatric patients in the United States. The system introduced a rechargeable powered driver, five needle-length options, stabilization features, and passive needle-tip safety. The launch broadened competition in rapid access for shock, trauma, cardiac arrest, and other situations in which peripheral or central venous placement may be delayed.

In August 2025, the FDA found Access Vascular’s updated HydroPICC and HydroMID devices substantially equivalent under the 510(k) pathway. The subsequent expanded labeling recognized anti-thrombogenic characteristics associated with the company’s drug-free hydrogel material. This is commercially significant because thrombosis and occlusion are major drivers of catheter replacement and treatment disruption. The clearance supports a broader market trend in which vascular access manufacturers compete through material science and complication reduction rather than only lumen configuration and price.

In September 2025, ICU Medical announced FDA-cleared labeling claims for its Clave needlefree connector portfolio based on real-world evidence from approximately 3,000 hospitals and nearly 17.5 million catheter-days. The analysis cited a 19% reduction in relative CLABSI risk among hospitals with high Clave utilization. This development strengthens the role of connectors in hospital infection-prevention strategy and may encourage value-analysis committees to evaluate connector technology as a quality intervention rather than a commodity accessory.

Hospitals are also expanding the use of ultrasound-guided peripheral access, long peripheral catheters, and midlines as alternatives to repeated short-PIV failure or unnecessary central-line placement. The clinical objective is to match the device to expected therapy duration and vessel characteristics from the beginning. This trend is increasing demand for portable ultrasound, vessel-measurement software, guidewire-assisted insertion, longer catheters, competency training, and standardized escalation protocols.

The competitive landscape is being shaped by portfolio consolidation and cross-selling. Large manufacturers are integrating catheters, connectors, securement, infusion consumables, and guidance platforms, while specialized companies are seeking partnerships that provide access to national hospital contracts. Distributor influence remains high because hospitals want supply continuity and simplified logistics. At the same time, shortages and recalls have increased buyer attention to dual sourcing, domestic or regional manufacturing resilience, packaging efficiency, and product substitution planning.

Regulatory and reimbursement dynamics continue to favor clinically justified innovation but do not guarantee premium adoption. Most vascular access devices enter through the FDA 510(k) pathway, making substantial equivalence, labeling claims, and post-market evidence central to differentiation. Reimbursement is usually embedded within hospital, outpatient, dialysis, or home-infusion payment rather than paid as a separate device line. Manufacturers must therefore build an economic case around avoided labor, complications, delays, and downstream utilization. Products that do not create a measurable operational or clinical advantage remain exposed to aggressive contracting pressure.

Conclusion

The U.S. Vascular Access Devices Market Size & Share is positioned for sustained expansion from USD 1.47 billion in 2025 to approximately USD 2.78 billion by 2035, supported by a 6.58% CAGR during the forecast period. The market’s long-term strength is grounded in very high procedure frequency, the scale of hospital care, more than 2.04 million annual cancer diagnoses, continued end-stage kidney disease treatment demand, persistent difficult-access challenges, and the need to reduce catheter-related infection, occlusion, thrombosis, infiltration, and dislodgement.

The most attractive growth opportunities will come from safety-engineered peripheral IV systems, midlines, anti-thrombogenic PICCs, closed and blood-control catheter systems, ultrasound-guided access, ECG-based tip confirmation, intraosseous devices, infection-prevention connectors, and evidence-supported securement. Mature conventional catheters will remain essential, but revenue growth will increasingly depend on products that improve successful therapy days and reduce the hidden cost of failed access.

Regional opportunity will be led by the South because of population scale, chronic disease burden, and hospital expansion. The West is expected to grow fastest due to population migration, technology adoption, and digital workflow integration. The Northeast will remain a premium market for academic, oncology, and high-acuity care, while the Midwest will provide stable recurring demand and durable system-standardization opportunities. Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, New Jersey, Tennessee, and Virginia will be especially important state markets for manufacturers, distributors, and investors.

For clients evaluating this market, the central strategic question is not whether vascular access demand will persist. The more important questions are which devices will reduce total cost per completed therapy course, where hospitals will shift from conventional to premium systems, how outpatient and home infusion will change product requirements, and which suppliers can translate clinical evidence into enterprise contracts. Companies that combine reliable devices, workflow integration, infection-prevention evidence, supply resilience, and implementation support will define the next decade of the U.S. vascular access devices industry.

TABLE OF CONTENT

1. U.S. Vascular Access Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Vascular Access Device Manufacturers
1.6.2. Raw Material, Component, and Contract Manufacturing Suppliers
1.6.3. Hospitals, Integrated Delivery Networks, and Vascular Access Teams
1.6.4. Oncology, Dialysis, Infusion, and Specialty Care Providers
1.6.5. Ambulatory, Home Infusion, and Post-Acute Care Providers
1.6.6. Group Purchasing Organizations, Distributors, and Specialty Suppliers
1.6.7. Payers, Regulators, Infection Prevention Teams, and Clinical Decision-Makers
What this section provides: This section defines the market boundary, study scope, methodology, assumptions, and stakeholder ecosystem used to measure and validate the U.S. vascular access devices market.

2. U.S. Vascular Access Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
What this section provides: This section gives decision-makers a concise view of market size, growth direction, major demand pockets, competitive intensity, and priority opportunity areas across the U.S. vascular access ecosystem.

3. U.S. Vascular Access Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Hospital Admissions and Intravenous Therapy Utilization
3.1.2. Expanding Cancer Treatment, Chemotherapy, and Long-Term Infusion Demand
3.1.3. Growth in Hemodialysis and Chronic Kidney Disease Care
3.1.4. Increasing Critical Care, Emergency, and Difficult-Vascular-Access Procedures
3.1.5. Hospital Focus on First-Stick Success, Dwell Time, and Workflow Efficiency
3.1.6. Infection Prevention and Catheter-Related Complication Reduction
3.2. Restraints and Their Impact Analysis
3.2.1. Catheter-Related Bloodstream Infection, Thrombosis, Occlusion, and Infiltration Risk
3.2.2. Price Pressure, Product Standardization, and Value Analysis Scrutiny
3.2.3. Skilled Inserter and Vascular Access Workforce Constraints
3.2.4. Product Recall, Material Safety, and Supply Reliability Risk
3.3. Opportunities and Their Impact Analysis
3.3.1. Antimicrobial and Antithrombogenic Catheter Adoption
3.3.2. Expansion of Midline and PICC Programs
3.3.3. Ultrasound-Guided Insertion and Tip-Confirmation Technologies
3.3.4. Outpatient, Home Infusion, and Post-Acute Vascular Access
3.3.5. Smart Connectors, Closed Systems, and Digital Line Management
3.3.6. Difficult-Vascular-Access Pathways and Device Selection Algorithms
3.4. Challenges and Their Impact Analysis
3.4.1. Variation in Clinical Protocols and Device Selection Practices
3.4.2. Balancing Dwell Duration, Complication Risk, and Total Episode Cost
3.4.3. Training, Competency Maintenance, and Ultrasound Adoption
3.4.4. Supply Chain Dependence for Medical-Grade Polymers and Sterile Components
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital and Consumables Procurement Behavior Analysis
What this section provides: This section explains the clinical, operational, reimbursement, procurement, and infection-prevention forces shaping vascular access demand, helping clients assess opportunity size and execution risk.

4. U.S. Vascular Access Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Integrated Vascular Access Management
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Infection-Prevention and Patient-Safety Initiatives
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, technology adoption, infection prevention, and hospital purchasing dynamics.

5. U.S. Vascular Access Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Peripheral Intravenous Catheters
5.1.2.1. Short Peripheral Intravenous Catheters
5.1.2.2. Safety Peripheral Intravenous Catheters
5.1.2.3. Closed-System Peripheral Intravenous Catheters
5.1.3. Midline Catheters
5.1.3.1. Standard Midline Catheters
5.1.3.2. Power-Injectable Midline Catheters
5.1.4. Peripherally Inserted Central Catheters
5.1.4.1. Single-Lumen PICCs
5.1.4.2. Double-Lumen PICCs
5.1.4.3. Multi-Lumen PICCs
5.1.4.4. Power-Injectable PICCs
5.1.5. Central Venous Catheters
5.1.5.1. Non-Tunneled Central Venous Catheters
5.1.5.2. Tunneled Central Venous Catheters
5.1.5.3. Antimicrobial and Antithrombogenic Central Venous Catheters
5.1.6. Implantable Ports
5.1.6.1. Single-Lumen Implantable Ports
5.1.6.2. Double-Lumen Implantable Ports
5.1.6.3. Power-Injectable Implantable Ports
5.1.7. Hemodialysis Catheters
5.1.7.1. Acute Hemodialysis Catheters
5.1.7.2. Chronic Tunneled Hemodialysis Catheters
5.1.8. Vascular Access Accessories
5.1.8.1. Needleless Connectors
5.1.8.2. Catheter Securement and Stabilization Devices
5.1.8.3. Disinfection Caps and Port Protectors
5.1.8.4. Guidewires, Introducers, and Placement Kits
What this section provides: This section identifies the vascular access product categories and subcategories expected to generate the highest revenue contribution, recurring consumable demand, and strongest growth through 2035.

6. U.S. Vascular Access Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Medication and Fluid Administration
6.1.2.1. Short-Term Intravenous Therapy
6.1.2.2. Long-Term Antibiotic and Specialty Drug Infusion
6.1.3. Chemotherapy and Oncology Care
6.1.3.1. Inpatient Oncology Infusion
6.1.3.2. Outpatient Chemotherapy
6.1.3.3. Long-Term Implantable Port Access
6.1.4. Parenteral Nutrition
6.1.4.1. Hospital Parenteral Nutrition
6.1.4.2. Home Parenteral Nutrition
6.1.5. Blood Transfusion and Blood Sampling
6.1.5.1. Transfusion Therapy
6.1.5.2. Repeated Blood Sampling and Diagnostic Access
6.1.6. Hemodialysis and Renal Replacement Therapy
6.1.6.1. Acute Dialysis Access
6.1.6.2. Chronic Dialysis Access
6.1.7. Critical Care and Emergency Access
6.1.7.1. Intensive Care and Hemodynamic Support
6.1.7.2. Trauma, Emergency, and Rapid Infusion
6.1.8. Other Applications
6.1.8.1. Contrast Media Injection
6.1.8.2. Apheresis and Specialty Procedures
What this section provides: This section helps clients understand vascular access demand by clinical use case and prioritize applications with high procedure volume, long dwell requirements, recurring consumable utilization, and strong complication-avoidance value.

7. U.S. Vascular Access Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic Medical Centers
7.1.2.2. Community Hospitals
7.1.2.3. Critical Access and Rural Hospitals
7.1.3. Oncology Centers and Infusion Clinics
7.1.4. Dialysis Centers
7.1.5. Ambulatory Surgery Centers and Specialty Clinics
7.1.6. Home Infusion and Home Healthcare Providers
7.1.7. Skilled Nursing, Rehabilitation, and Long-Term Care Facilities
What this section provides: This section explains which care settings and customer groups are expected to drive device purchasing, line placement, replacement demand, and long-term vascular access utilization.

8. U.S. Vascular Access Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Vascular Access Devices
8.1.3. Safety-Engineered Vascular Access Devices
8.1.4. Antimicrobial and Antithrombogenic Devices
8.1.5. Power-Injectable Vascular Access Devices
8.1.6. Ultrasound-Guided and Navigation-Enabled Access Technologies
8.1.6.1. Ultrasound-Guided Placement Systems
8.1.6.2. ECG-Based Tip-Confirmation Systems
8.1.6.3. Magnetic and Electromagnetic Navigation Systems
8.1.7. Needleless and Closed-System Access Technologies
8.1.7.1. Needleless Connectors
8.1.7.2. Closed Catheter Systems
8.1.7.3. Disinfection and Line-Protection Technologies
What this section provides: This section evaluates the safety, coating, power-injection, placement, navigation, and closed-system technologies reshaping vascular access outcomes and hospital purchasing preferences.

9. U.S. Vascular Access Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.6. Oncology, Dialysis, and Infusion-Network Procurement
9.1.7. Home Infusion and Post-Acute Procurement
What this section provides: This section helps clients understand how vascular access products are purchased in the U.S., including IDN standardization, GPO contracting, specialty-channel influence, and outpatient or home-based procurement behavior.

10. U.S. Vascular Access Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital, Oncology, Dialysis, and Infusion Infrastructure Analysis
10.1.4. Regional Procedure Volume, Clinical Practice, and Vascular Access Team Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Vascular Access Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Vascular Access Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Vascular Access Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Vascular Access Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, hospital and infusion-volume hubs, vascular access adoption hotspots, clinical-practice differences, and state-level commercial opportunities.

11. U.S. Vascular Access Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Becton, Dickinson and Company (BD)
11.3.2. Teleflex Incorporated
11.3.3. B. Braun Medical Inc.
11.3.4. ICU Medical, Inc.
11.3.5. AngioDynamics, Inc.
11.3.6. Medtronic plc
11.3.7. Cook Medical
11.3.8. Terumo Corporation
11.3.9. Cardinal Health, Inc.
11.3.10. Medline Industries, LP
11.3.11. Merit Medical Systems, Inc.
11.3.12. Fresenius Medical Care
11.3.13. Nipro Corporation
11.3.14. Baxter International Inc.
11.3.15. Vygon USA
11.3.16. Argon Medical Devices, Inc.
11.3.17. Access Vascular, Inc.
11.3.18. Linear Health Sciences
11.3.19. Adhezion Biomedical, LLC
11.3.20. 3M Company
11.3.21. CorMedix Inc.
11.3.22. Medical Components, Inc. (Medcomp)
11.3.23. Romsons
11.3.24. Poly Medicure Limited
11.3.25. Kimal plc
Note: Each company profile will include company overview, vascular access portfolio, U.S. market strategy, financial positioning, clinical evidence, regulatory updates, partnerships, manufacturing and supply capabilities, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, innovation direction, channel strategy, and strategic intelligence on major vascular access device companies.

12. U.S. Vascular Access Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Antimicrobial and Antithrombogenic Catheter Platforms
12.2.2. Ultrasound-Guided Placement and AI-Assisted Vessel Assessment
12.2.3. ECG and Navigation-Based Tip-Confirmation Systems
12.2.4. Smart Needleless Connectors and Closed-System Line Management
12.2.5. Advanced Polymers, Coatings, and Material Innovation
12.2.6. Digital Vascular Access Surveillance and Complication Prediction
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
What this section provides: This section prepares clients for future technology shifts, clinical-practice changes, market structure evolution, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Vascular Access Devices Market: Strategic Recommendations

13.1. Recommendations for Device Manufacturers
13.2. Recommendations for Hospitals, IDNs, and Vascular Access Teams
13.3. Recommendations for Investors and Private Equity Firms
13.4. Recommendations for Distributors and Channel Partners
13.5. Recommendations for New Entrants and Startups
13.6. Go-to-Market Strategy Considerations
13.7. Product Positioning and Portfolio Expansion Guidance
13.8. Clinical Evidence, Health Economics, and Contracting Priorities
What this section provides: This section converts market intelligence into actionable strategy for product development, portfolio positioning, channel expansion, clinical adoption, investment decisions, and competitive differentiation.

14. U.S. Vascular Access Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, and forecasting assumptions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Vascular Access Devices Market: Market Definition and Scope
TABLE 3: U.S. Vascular Access Devices Market: Research Methodology Framework
TABLE 4: U.S. Vascular Access Devices Market: Key Assumptions
TABLE 5: U.S. Vascular Access Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Vascular Access Devices Market: Stakeholder Analysis
TABLE 7: U.S. Vascular Access Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Vascular Access Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Vascular Access Devices Market: Market Attractiveness Index
TABLE 10: U.S. Vascular Access Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Vascular Access Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Vascular Access Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Vascular Access Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Vascular Access Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Vascular Access Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Vascular Access Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Vascular Access Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Vascular Access Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Vascular Access Devices Market: Hospital Capital and Consumables Procurement Behavior Matrix
TABLE 20: U.S. Vascular Access Devices Market: PESTEL Analysis
TABLE 21: U.S. Vascular Access Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Vascular Access Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Vascular Access Devices Market: Value Chain Analysis
TABLE 24: U.S. Vascular Access Devices Market: Supply Chain Analysis
TABLE 25: U.S. Vascular Access Devices Market: Digitalization and Integrated Vascular Access Management Impact
TABLE 26: U.S. Vascular Access Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Vascular Access Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Vascular Access Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Vascular Access Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Vascular Access Devices Market: Government Infection-Prevention and Patient-Safety Initiatives
TABLE 31: U.S. Vascular Access Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 32: U.S. Vascular Access Devices Market: Product Type Snapshot, 2025
TABLE 33: Segment Dashboard; Definition and Scope, by Product Type
TABLE 34: U.S. Vascular Access Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 35: U.S. Vascular Access Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 36: U.S. Vascular Access Devices Market: Peripheral Intravenous Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 37: U.S. Vascular Access Devices Market: Midline Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Vascular Access Devices Market: Peripherally Inserted Central Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Vascular Access Devices Market: Central Venous Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Vascular Access Devices Market: Implantable Ports Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Vascular Access Devices Market: Hemodialysis Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Vascular Access Devices Market: Vascular Access Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Vascular Access Devices Market: Application Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Application
TABLE 45: U.S. Vascular Access Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 46: U.S. Vascular Access Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 47: U.S. Vascular Access Devices Market: Medication and Fluid Administration Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Vascular Access Devices Market: Chemotherapy and Oncology Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Vascular Access Devices Market: Parenteral Nutrition Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Vascular Access Devices Market: Blood Transfusion and Blood Sampling Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Vascular Access Devices Market: Hemodialysis and Renal Replacement Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Vascular Access Devices Market: Critical Care and Emergency Access Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Vascular Access Devices Market: Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Vascular Access Devices Market: End User Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by End User
TABLE 56: U.S. Vascular Access Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 57: U.S. Vascular Access Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 58: U.S. Vascular Access Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Vascular Access Devices Market: Oncology Centers and Infusion Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Vascular Access Devices Market: Dialysis Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Vascular Access Devices Market: Ambulatory Surgery Centers and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Vascular Access Devices Market: Home Infusion and Home Healthcare Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Vascular Access Devices Market: Skilled Nursing, Rehabilitation, and Long-Term Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Vascular Access Devices Market: Technology Type Snapshot, 2025
TABLE 65: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 66: U.S. Vascular Access Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 67: U.S. Vascular Access Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 68: U.S. Vascular Access Devices Market: Conventional Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Vascular Access Devices Market: Safety-Engineered Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Vascular Access Devices Market: Antimicrobial and Antithrombogenic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Vascular Access Devices Market: Power-Injectable Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Vascular Access Devices Market: Ultrasound-Guided and Navigation-Enabled Access Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Vascular Access Devices Market: Needleless and Closed-System Access Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Vascular Access Devices Market: Procurement Channel Snapshot, 2025
TABLE 75: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 76: U.S. Vascular Access Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 77: U.S. Vascular Access Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 78: U.S. Vascular Access Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Vascular Access Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Vascular Access Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Vascular Access Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Vascular Access Devices Market: Oncology, Dialysis, and Infusion-Network Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Vascular Access Devices Market: Home Infusion and Post-Acute Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Vascular Access Devices Market: Regional Snapshot, 2025
TABLE 85: Segment Dashboard; Definition and Scope, by Region
TABLE 86: U.S. Vascular Access Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 87: U.S. Vascular Access Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 88: West Region U.S. Vascular Access Devices Market: Regional Overview and Trends
TABLE 89: West Region U.S. Vascular Access Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 90: West Region U.S. Vascular Access Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Vascular Access Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Vascular Access Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Vascular Access Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Vascular Access Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Vascular Access Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 96: California Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Washington Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Arizona Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Colorado Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Oregon Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Utah Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Nevada Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: New Mexico Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Idaho Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Montana Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Wyoming Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Alaska Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Hawaii Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Vascular Access Devices Market: Regional Overview and Trends
TABLE 110: Northeast Region U.S. Vascular Access Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 111: Northeast Region U.S. Vascular Access Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Vascular Access Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Vascular Access Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Vascular Access Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Vascular Access Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Vascular Access Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: New York Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Massachusetts Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: New Jersey Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Pennsylvania Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Connecticut Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Maine Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Vermont Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: New Hampshire Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Rhode Island Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Delaware Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: South Region U.S. Vascular Access Devices Market: Regional Overview and Trends
TABLE 128: South Region U.S. Vascular Access Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 129: South Region U.S. Vascular Access Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Vascular Access Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 131: South Region U.S. Vascular Access Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Vascular Access Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Vascular Access Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Vascular Access Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Texas Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Florida Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Georgia Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: North Carolina Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Tennessee Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: South Carolina Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Alabama Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Mississippi Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Louisiana Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Arkansas Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Kentucky Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Oklahoma Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Virginia Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Maryland Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: West Virginia Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region U.S. Vascular Access Devices Market: Regional Overview and Trends
TABLE 151: Midwest Region U.S. Vascular Access Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 152: Midwest Region U.S. Vascular Access Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. Vascular Access Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Vascular Access Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Vascular Access Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Vascular Access Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Vascular Access Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Illinois Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Ohio Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Michigan Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Minnesota Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Indiana Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Wisconsin Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Missouri Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Iowa Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Kansas Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Nebraska Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: North Dakota Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: South Dakota Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: U.S. Vascular Access Devices Market: Competitive Landscape Snapshot, 2025
TABLE 171: U.S. Vascular Access Devices Market: Key Company Market Share Analysis, 2025
TABLE 172: U.S. Vascular Access Devices Market: Company Positioning Matrix
TABLE 173: U.S. Vascular Access Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 174: U.S. Vascular Access Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 175: Becton, Dickinson and Company (BD): Company Profile
TABLE 176: Teleflex Incorporated: Company Profile
TABLE 177: B. Braun Medical Inc.: Company Profile
TABLE 178: ICU Medical, Inc.: Company Profile
TABLE 179: AngioDynamics, Inc.: Company Profile
TABLE 180: Medtronic plc: Company Profile
TABLE 181: Cook Medical: Company Profile
TABLE 182: Terumo Corporation: Company Profile
TABLE 183: Cardinal Health, Inc.: Company Profile
TABLE 184: Medline Industries, LP: Company Profile
TABLE 185: Merit Medical Systems, Inc.: Company Profile
TABLE 186: Fresenius Medical Care: Company Profile
TABLE 187: Nipro Corporation: Company Profile
TABLE 188: Baxter International Inc.: Company Profile
TABLE 189: Vygon USA: Company Profile
TABLE 190: Argon Medical Devices, Inc.: Company Profile
TABLE 191: Access Vascular, Inc.: Company Profile
TABLE 192: Linear Health Sciences: Company Profile
TABLE 193: Adhezion Biomedical, LLC: Company Profile
TABLE 194: 3M Company: Company Profile
TABLE 195: CorMedix Inc.: Company Profile
TABLE 196: Medical Components, Inc. (Medcomp): Company Profile
TABLE 197: Romsons: Company Profile
TABLE 198: Poly Medicure Limited: Company Profile
TABLE 199: Kimal plc: Company Profile
TABLE 200: U.S. Vascular Access Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 201: U.S. Vascular Access Devices Market: Disruptive Technologies Impact Matrix
TABLE 202: U.S. Vascular Access Devices Market: Emerging Business Trends
TABLE 203: U.S. Vascular Access Devices Market: Business Opportunities for Startups and Existing Players
TABLE 204: U.S. Vascular Access Devices Market: Investment Prioritization Matrix
TABLE 205: U.S. Vascular Access Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 206: U.S. Vascular Access Devices Market: Strategic Recommendations for Hospitals, IDNs, and Vascular Access Teams
TABLE 207: U.S. Vascular Access Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 208: U.S. Vascular Access Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 209: U.S. Vascular Access Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 210: U.S. Vascular Access Devices Market: Go-to-Market Strategy Considerations
TABLE 211: U.S. Vascular Access Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 212: U.S. Vascular Access Devices Market: Clinical Evidence, Health Economics, and Contracting Priorities
TABLE 213: U.S. Vascular Access Devices Market: Scope Limitation
TABLE 214: U.S. Vascular Access Devices Market: Data Use Limitation
TABLE 215: U.S. Vascular Access Devices Market: Forecasting Limitation
TABLE 216: U.S. Vascular Access Devices Market: Legal Disclaimer
TABLE 217: U.S. Vascular Access Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Vascular Access Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Overview
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital and Consumables Procurement Decision Framework
FIGURE 13: U.S. Vascular Access Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. Vascular Access Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. Vascular Access Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Peripheral Intravenous Catheters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Midline Catheters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Peripherally Inserted Central Catheters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Central Venous Catheters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Implantable Ports Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Hemodialysis Catheters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Vascular Access Accessories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Medication and Fluid Administration Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Chemotherapy and Oncology Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Parenteral Nutrition Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Blood Transfusion and Blood Sampling Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Hemodialysis and Renal Replacement Therapy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Critical Care and Emergency Access Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Other Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 35: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Oncology Centers and Infusion Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Dialysis Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Ambulatory Surgery Centers and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Home Infusion and Home Healthcare Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Skilled Nursing, Rehabilitation, and Long-Term Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Conventional Vascular Access Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Safety-Engineered Vascular Access Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Antimicrobial and Antithrombogenic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Power-Injectable Vascular Access Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Ultrasound-Guided and Navigation-Enabled Access Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Needleless and Closed-System Access Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Oncology, Dialysis, and Infusion-Network Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Home Infusion and Post-Acute Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 59: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: West Region U.S. Vascular Access Devices Market Share and Leading Players, 2025
FIGURE 61: West Region Market Share Analysis by State, 2025
FIGURE 62: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: California Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Washington Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Arizona Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Colorado Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Oregon Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Utah Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Nevada Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: New Mexico Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Idaho Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Montana Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Wyoming Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Alaska Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Hawaii Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Northeast Region U.S. Vascular Access Devices Market Share and Leading Players, 2025
FIGURE 77: Northeast Region Market Share Analysis by State, 2025
FIGURE 78: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New York Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Massachusetts Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New Jersey Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Pennsylvania Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Connecticut Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Maine Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Vermont Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: New Hampshire Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Rhode Island Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Delaware Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Region U.S. Vascular Access Devices Market Share and Leading Players, 2025
FIGURE 90: South Region Market Share Analysis by State, 2025
FIGURE 91: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Texas Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Florida Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Georgia Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: North Carolina Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Tennessee Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: South Carolina Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Alabama Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Mississippi Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Louisiana Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Arkansas Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Kentucky Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Oklahoma Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Virginia Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Maryland Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: West Virginia Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Midwest Region U.S. Vascular Access Devices Market Share and Leading Players, 2025
FIGURE 108: Midwest Region Market Share Analysis by State, 2025
FIGURE 109: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Illinois Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Ohio Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Michigan Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Minnesota Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Indiana Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Wisconsin Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Missouri Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Iowa Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Kansas Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Nebraska Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: North Dakota Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: South Dakota Vascular Access Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 123: Company Positioning Matrix
FIGURE 124: Key Player Product Portfolio Benchmarking
FIGURE 125: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 126: Vascular Access Device Innovation Roadmap
FIGURE 127: Antimicrobial and Antithrombogenic Catheter Adoption Roadmap
FIGURE 128: Ultrasound-Guided Placement and Vessel Assessment Opportunity Map
FIGURE 129: Tip-Confirmation and Navigation Technology Roadmap
FIGURE 130: Smart Connector and Closed-System Access Growth Roadmap
FIGURE 131: Future Market Scenario Analysis, 2026–2035
FIGURE 132: Disruptive Technologies Impact Matrix
FIGURE 133: Emerging Business Trends Matrix
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: Strategic Growth Roadmap for U.S. Vascular Access Device Companies
FIGURE 136: Go-to-Market Strategy Framework
FIGURE 137: Product Positioning and Portfolio Expansion Framework
FIGURE 138: Report Scope and Disclaimer Framework